MY136769A - Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them - Google Patents

Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them

Info

Publication number
MY136769A
MY136769A MYPI20042944A MYPI20042944A MY136769A MY 136769 A MY136769 A MY 136769A MY PI20042944 A MYPI20042944 A MY PI20042944A MY PI20042944 A MYPI20042944 A MY PI20042944A MY 136769 A MY136769 A MY 136769A
Authority
MY
Malaysia
Prior art keywords
heparin
pharmaceutical compositions
compositions containing
preparation
mixtures derived
Prior art date
Application number
MYPI20042944A
Inventor
Laux Volker
Mourier Pierre
Viskov Christian
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MY136769A publication Critical patent/MY136769A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

THE PRESENT INVENTION RELATES TO OLIGOSACCHARIDE MIXTURES DERIVED FROM HEPARIN, WITH AN AVERAGE MOLECULAR WEIGHT OF FROM 1800 TO 2400 DALTONS, CHARACTERIZED BY HIGH AXA ACTIVITY AND AN ABSENCE OF AIIA ACTIVITY, TO A PROCESS FOR PREPARING THEM AND TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MYPI20042944A 2003-07-24 2004-07-22 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them MY136769A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0309041A FR2857971B1 (en) 2003-07-24 2003-07-24 MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
MY136769A true MY136769A (en) 2008-11-28

Family

ID=33561051

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20042944A MY136769A (en) 2003-07-24 2004-07-22 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them

Country Status (40)

Country Link
EP (1) EP1651677B1 (en)
JP (1) JP4865552B2 (en)
KR (1) KR101125517B1 (en)
CN (1) CN1852926B (en)
AR (1) AR045917A1 (en)
AT (1) ATE487741T1 (en)
AU (1) AU2004259111B2 (en)
BR (1) BRPI0412850A (en)
CA (1) CA2533555A1 (en)
CR (1) CR8201A (en)
CY (1) CY1111165T1 (en)
DE (1) DE602004030015D1 (en)
DK (1) DK1651677T3 (en)
EC (1) ECSP066305A (en)
ES (1) ES2355827T3 (en)
FR (1) FR2857971B1 (en)
GT (1) GT200400145A (en)
HK (1) HK1094806A1 (en)
HN (1) HN2004000250A (en)
IL (1) IL173206A (en)
MA (1) MA27928A1 (en)
ME (1) MEP11608A (en)
MX (1) MXPA06000336A (en)
MY (1) MY136769A (en)
NO (1) NO20060821L (en)
NZ (1) NZ544717A (en)
OA (1) OA13197A (en)
PA (1) PA8606801A1 (en)
PE (1) PE20050246A1 (en)
PL (1) PL1651677T3 (en)
PT (1) PT1651677E (en)
RS (1) RS20060044A (en)
RU (1) RU2346005C2 (en)
SI (1) SI1651677T1 (en)
TN (1) TNSN06025A1 (en)
TW (1) TWI369208B (en)
UA (1) UA89356C2 (en)
UY (1) UY28435A1 (en)
WO (1) WO2005010051A2 (en)
ZA (1) ZA200600657B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589145B2 (en) 2004-04-15 2009-09-15 Exxonmobil Chemical Patents Inc. Syndiotactic rich polyolefins
CN101495517B (en) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 Low molecular weight heparin composition and uses thereof
CN101711771B (en) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 A kind of polysaccharide mixture of heparin derivative and method for making thereof and pharmaceutical composition
CA3020369C (en) * 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (en) * 2010-12-14 2012-07-11 王芃 Preparation method of high-FXa-resistant low-FIIa-resistant low-molecular heparin sodium
CN102816255B (en) * 2011-06-10 2015-11-25 王芃 A kind of preparation method of ultra-low molecular heparin sodium
WO2014153995A1 (en) * 2013-03-26 2014-10-02 中国科学院昆明植物研究所 Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103864959A (en) * 2014-04-03 2014-06-18 中国药科大学 Application of heparin oligosaccharide dp12 in atherosclerosis resistance
RU2639574C2 (en) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Process for low molecular weight heparin preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (en) * 1981-04-29 1982-11-05 Choay Sa SHORT CHAIN OLIGOSACCHARIDES HAVING BIOLOGICAL PROPERTIES, PREPARATION THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS
WO1998055515A1 (en) * 1997-06-06 1998-12-10 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
ES2161615B1 (en) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa COMPOSITIONS OF HEPARINS OF VERY LOW MOLECULAR WEIGHT.
JP4897991B2 (en) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ Ultra low molecular weight heparin composition
FR2800074B1 (en) * 1999-10-22 2001-12-21 Aventis Pharma Sa NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP4585072B2 (en) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 Heparin depolymerization method, depolymerized heparin, derivatives thereof and pharmaceutical composition
FR2807043B1 (en) * 2000-03-28 2002-11-22 Aventis Pharma Sa PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION
FR2811992B1 (en) * 2000-07-21 2003-07-04 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
WO2003018032A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
ATE487741T1 (en) 2010-11-15
AU2004259111B2 (en) 2009-06-11
HN2004000250A (en) 2006-06-29
SI1651677T1 (en) 2011-03-31
ECSP066305A (en) 2006-07-28
DE602004030015D1 (en) 2010-12-23
RS20060044A (en) 2008-06-05
CN1852926B (en) 2010-05-12
CR8201A (en) 2006-09-22
KR20060059974A (en) 2006-06-02
IL173206A (en) 2010-11-30
KR101125517B1 (en) 2012-03-23
UY28435A1 (en) 2005-02-28
HK1094806A1 (en) 2007-04-13
GT200400145A (en) 2005-03-16
EP1651677A2 (en) 2006-05-03
FR2857971B1 (en) 2005-08-26
PT1651677E (en) 2011-02-08
MXPA06000336A (en) 2006-03-30
AU2004259111A1 (en) 2005-02-03
PE20050246A1 (en) 2005-06-02
WO2005010051A3 (en) 2005-06-16
RU2006105384A (en) 2007-09-10
AR045917A1 (en) 2005-11-16
RU2346005C2 (en) 2009-02-10
TNSN06025A1 (en) 2007-10-03
PL1651677T3 (en) 2011-04-29
FR2857971A1 (en) 2005-01-28
EP1651677B1 (en) 2010-11-10
TW200522970A (en) 2005-07-16
UA89356C2 (en) 2010-01-25
CA2533555A1 (en) 2005-02-03
JP2006528614A (en) 2006-12-21
ZA200600657B (en) 2007-05-30
NO20060821L (en) 2006-04-20
CY1111165T1 (en) 2015-06-11
BRPI0412850A (en) 2006-10-03
PA8606801A1 (en) 2005-02-04
CN1852926A (en) 2006-10-25
TWI369208B (en) 2012-08-01
IL173206A0 (en) 2006-06-11
WO2005010051A2 (en) 2005-02-03
MEP11608A (en) 2010-06-10
DK1651677T3 (en) 2011-02-28
NZ544717A (en) 2009-09-25
MA27928A1 (en) 2006-06-01
ES2355827T3 (en) 2011-03-31
OA13197A (en) 2006-12-13
JP4865552B2 (en) 2012-02-01

Similar Documents

Publication Publication Date Title
MY142376A (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
CY1111165T1 (en) MIXES OF OLIGOSACHARS COMING FROM USRIN, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOUNDS CONTAINING THEM
EP2085780A3 (en) Methods and products related to low molecular weight heparin
MXPA05010682A (en) Novel compounds.
BRPI0413241A (en) monatin table sweetener compositions and methods of making the same
SG148997A1 (en) Powders comprising low molecular dextran and methods of producing those powders
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
HRP20020330A2 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
EP1561760A3 (en) Low molecular weight heparin salt with thriethanolamine
GB0216002D0 (en) Process and composition
BRPI0413346A (en) polysaccharide derivatives with high antithrombotic plasma activity
HK1098352A1 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
WO2004017910A3 (en) Total synthesis of heparin
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
NO20030073L (en) Drug delivery system for drugs that are not water soluble
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
HK1042499A1 (en) Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
MA28668B1 (en) VEGETABLE PRODUCT COMPRISING PROANTHOCYANIDINES AND PROCESS FOR PREPARING THE SAME
PL1615656T3 (en) Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
IL171981A (en) Glycosaminoglycans for treatment of emotional dysfunctions
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
ATE552004T1 (en) ORAL HEPARINE DERIVATIVES
TH71829A (en) A mixture of oligosaccharides derived from Heparin Preparation of these mixtures And pharmacological mixtures containing these mixtures
TH68733A (en) Mixtures of polysaccharide derived from heparin Pharmaceutical preparations and mixtures containing them